Zarogoulidis, P., Mavroudi, M., Porpodis, K., Domvri, K., Sakkas, A., Machairiotis, N., . . . Zarogoulidis, K. (2012). Pegylated liposomal doxorubicin in malignant pleural mesothelioma: A possible guardian for long-term survival. Dove Medical Press.
Chicago Style CitationZarogoulidis, Paul, et al. Pegylated Liposomal Doxorubicin in Malignant Pleural Mesothelioma: A Possible Guardian for Long-term Survival. Dove Medical Press, 2012.
MLA CitationZarogoulidis, Paul, et al. Pegylated Liposomal Doxorubicin in Malignant Pleural Mesothelioma: A Possible Guardian for Long-term Survival. Dove Medical Press, 2012.
Warning: These citations may not always be 100% accurate.